Prednisolone and Leukaemic infiltration - a phase IV clinical study of FDA data


Leukaemic infiltration is found among people who take Prednisolone, especially for people who are male, 50-59 old.

The phase IV clinical study analyzes which people take Prednisolone and have Leukaemic infiltration. It is created by eHealthMe based on reports of 180,802 people who have side effects when taking Prednisolone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

180,802 people reported to have side effects when taking Prednisolone.
Among them, 18 people (0.01%) have Leukaemic infiltration.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 182,055 Prednisolone users for its effectiveness, alternative drugs and more.

What is Leukaemic infiltration?

Leukaemic infiltration (change in leukaemia in which leukemic cells permeate various organs at any stage of the disease) is found to be associated with 121 drugs and 45 conditions by eHealthMe.

Number of Prednisolone and Leukaemic infiltration reports submitted per year:

Could Prednisolone cause Leukaemic infiltration?

Gender of people who have Leukaemic infiltration when taking Prednisolone *:

  • female: 6.25 %
  • male: 93.75 %

Age of people who have Leukaemic infiltration when taking Prednisolone *:

  • 0-1: 6.25 %
  • 2-9: 0.0 %
  • 10-19: 6.25 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 6.25 %
  • 50-59: 62.5 %
  • 60+: 18.75 %

Common drugs people take besides Prednisolone *:

  1. Warfarin Sodium: 1 person, 5.56%
  2. Venclexta: 1 person, 5.56%
  3. Ursodeoxycholic Acid: 1 person, 5.56%
  4. Tadalafil: 1 person, 5.56%
  5. Oncaspar: 1 person, 5.56%
  6. Nexium: 1 person, 5.56%
  7. Lenalidomide: 1 person, 5.56%
  8. Lansoprazole: 1 person, 5.56%
  9. Cyclosporine: 1 person, 5.56%
  10. Cyclophosphamide: 1 person, 5.56%

Common side effects people have besides Leukaemic infiltration *:

  1. Chickenpox (infection with varicella zoster virus): 11 people, 61.11%
  2. Drug Ineffective: 5 people, 27.78%
  3. Dermatosis (a disease of the skin, esp. one that does not cause inflammation): 5 people, 27.78%
  4. Rash Papular (redness with papule): 5 people, 27.78%
  5. Rashes (redness): 3 people, 16.67%
  6. Thrombocytopenia (decrease of platelets in blood): 2 people, 11.11%
  7. Tumor Lysis Syndrome: 2 people, 11.11%
  8. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 11.11%
  9. Diarrhea: 2 people, 11.11%
  10. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 5.56%

Common conditions people have *:

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 12 people, 66.67%
  2. T-Cell Lymphoma Stage Iv (one or more organs beyond the lymph nodes are affected with cancer of lymph node): 1 person, 5.56%
  3. Rashes (redness): 1 person, 5.56%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.56%
  5. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 1 person, 5.56%
  6. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 5.56%
  7. Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 1 person, 5.56%
  8. Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 1 person, 5.56%
  9. Actinic Keratosis (skin disease due to sun exposure): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone and have Leukaemic infiltration?

Check whether Leukaemic infiltration is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Leukaemic infiltration and when was it recovered:

Expand to all the drugs that have ingredients of prednisolone:

Alternative drugs to, pros and cons of Prednisolone:

Common Prednisolone side effects:

Browse all side effects of Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Leukaemic infiltration treatments and more:

COVID vaccines that are related to Leukaemic infiltration:

All the drugs that are associated with Leukaemic infiltration:

All the conditions that are associated with Leukaemic infiltration:

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prednisolone) and Prednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: